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urgency-based schedule. We agree with Beanlands and colleagues
that this could reduce some of the benefits of revascularization
when revascularization is delayed (2), but the urgency-based
schedule illustrates the clinical reality in an HMO-oriented health
care system.
We fully agree with Beanlands and colleagues that larger
randomized, controlled clinical trials are needed, and we are
pleased to hear that some are underway. In our opinion these
studies should address the role of various viability techniques
(PET, SPECT, echocardiography, magnetic resonance imaging)
in different patient populations (mild, moderate, severe LV dys-
function) and their cost-effectiveness. Preferably, these studies
should be conducted in a blinded fashion to prevent selection
biases, as we have demonstrated (1). Moreover, we believe these
studies should focus on patient management and clinical outcome,
because that is what is most important to patients in the everyday
clinical practice (3).
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Periodontal Disease and
Risk of Myocardial Infarction
As interesting and impressive as “Periodontal Disease and Risk of
Subsequent Cardiovascular Disease in U.S. Male Physicians” (1)
may be with its study of 22,037 participants, its conclusions are
likely to mislead readers and block further essential research on
that relationship. The conclusion, excluding a relationship, is in
direct conflict with the report of Deliargyris et al. (2) presented at
the annual meeting of the American Heart Association last
November as well as with my own report in Dentistry Today (3).
These latter two reports, contrariwise, “indicate that acute myo-
cardial infarction (AMI) patients are more likely to have periodon-
tal disease than a comparable control population without coronary
artery disease.”
Hardly recognized by the patient but easily identified by the
periodontist, gingivitis with .4-mm pockets (the criteria of
Deliargyris et al. (2) for periodontal disease predictive of acute
myocardial infarction) would have been largely overlooked by the
Howell et al. group (1). It seems almost certain, therefore, that the
Howell et al. (1) group of self-reported periodontal disease fails to
include many, if not most, cases with gingivitis with .4-mm
pockets, which the Deliargyris et al. (2) group found to be
predictive of AMI. This makes the sample unreliable for statistical
decision making; but even excluding this error, the Howell et al.
(1) group reported a “small (10% to 20%), and statistically
nonsignificant increased risk for nonfatal myocardial infarction,
nonfatal stroke and cardiovascular death” among the group that
self-reported periodontal disease.
Although controversy on this matter continues, further investi-
gation remains appropriate. During this time, the patient’s health
is likely to benefit; and both physicians and dentists are likely to
benefit, professionally, with continued cooperation in further
studies.
William H. Wehrmacher, MD, FACP, FACC
Loyola University Medical Center
2160 South First Avenue
Office 4644
Maywood, Illinois 60153
PII S0735-1097(01)01522-4
REFERENCES
1. Howell TH, Ridker PM, Ajani UA, Hennekens CH, Christen WG.
Periodontal disease and risk of subsequent cardiovascular disease in U.S.
male physicians. J Am Coll Cardiol 2001;37:445–50.
2. Deliargyris EN, Marron I, Smith SC, Madianos P, Beck JD, Offen-
bacher S. Periodontal disease and acute myocardial infarction (abstr).
Circulation 2000;102 Suppl II:II710.
3. Wehrmacher WH. Periodontal disease predictive and possibly contrib-
utive to acute myocardial infarction. Dentistry Today 2001;20:80–1.
REPLY
Dr. Wehrmacher expresses concern that reliance on participant
self-reports of periodontal disease in our analysis of periodontal
disease and subsequent cardiovascular disease in the Physicians’
Health Study (1) probably resulted in the failure to include some
cases of periodontal disease. We agree that some cases of peri-
odontal disease may have been missed. However, as discussed in
the study, the magnitude of any such misclassification (which is
likely to have been random with respect to subsequent cardiovas-
cular disease) is unlikely to have caused us to miss a two- to
threefold increased risk of cardiovascular disease reported in earlier
studies. Furthermore, as also discussed in the study, associations
were noted between reported periodontal disease and age and
cigarette smoking, two acknowledged risk factors for periodontal
disease, providing support for the validity of this measure in our
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